Shareholders Ask Judge To Approve $33M Settlement With Generic Drug Maker

(August 3, 2021, 1:42 PM EDT) -- SAN FRANCISCO — Shareholders on July 30 asked a federal judge in California to grant preliminary approval of a $33 million securities class action settlement in a lawsuit alleging that the defendants concealed the company’s involvement in an illegal generic drug price-fixing scheme with its competitors in the pharmaceutical industry....